Abstract: The present invention relates to the use of imaging for non-invasive and non-contact measurement of respiration rates and body temperature. The invention uses a combination of visible imaging, thermal imaging, and machine learning to monitor respiration rate and body temperature. One of the embodiments of the invention allows the invention to be mounted on an articulating arm for use in hospital settings. Another embodiment of the invention allows the invention to be easily portable for use in mobile applications. Further embodiments allow the system to be used remotely making it very applicable for use in isolation or for remote locations.

Abstract: Proposed is a green tide control agent containing hydrogen peroxide, a carboxylic acid compound, a ketone compound, and a flavonoid-based compound.

Abstract: Provided is an apparatus for estimating blood pressure, including a pulse wave sensor configured to measure a pulse wave signal of a user, and a processor configured to obtain, based on the pulse wave signal, one or more feature values corresponding to the blood pressure, detect whether a change in a posture of a user from a first posture to a second posture occurs while measuring the pulse wave signal, based on the change in the posture being detected, correct a reference blood pressure based on a blood pressure variation caused by the change in the posture, correct the one or more feature values based on a variation in one or more pulse wave signal feature values caused by the change in the posture, and estimate the blood pressure based on the corrected reference blood pressure and the corrected one or more feature values.

Abstract: There is disclosed vision quantification systems and methods designed to evaluate functional vision. Specifically, the systems are designed with the intent to track a subject's vision using mobility and dexterity assessments. More specifically, at least one aspect of the invention relates to the design and application of the systems in the functional vision assessments in patients with low vision.

Abstract: Embodiments are directed to a wearable device that can include a housing, a touch-sensitive display coupled to the housing, a band coupled to the housing and configured to secure the housing to a user, and a plurality of electrodes that contact the user when the wearable device is worn by the user. The wearable device can be configured to cause the plurality of electrodes to apply electrical signals to the user, measure the electrical signals from the user using the plurality of electrodes, generate a set of impedance data from the measured electrical signals, and identify one or more respiratory cycles using the set of impedance data.

Abstract: The present disclosure provides a juicer. The juicer can include a juicer body, a jog dial, and an indicator. The juicer body can include a face plate having an outer perimeter. The jog dial can be rotatably disposed on the face plate. The indicator can be disposed along a portion of the outer perimeter and can be configured to display a juicer status.

Abstract: A method of classifying, by an apparatus including a processor and a memory, a subject-independent driver state according to an embodiment of the present disclosure may include (a) learning a state classification model that receives one or more drivers' bio-signal data from a database to output the drivers' state classification (b) receiving a new driver's bio-signal, (c) preprocessing the received new driver's bio-signal, and (d) inputting the preprocessed new driver's bio-signal to the state classification model to output the driver's state classification result, wherein the bio-signal is at least one of an electroencephalogram (EEG), an electrooculogram (EOG), an electrocardiogram (ECG), and a photoplethysmogram (PPG).

Abstract: The present disclosure relates to a composition for anti-fatigue comprising a green tea peptide composition. Specifically, the green tea peptide composition according to the present disclosure exhibits anti-fatigue efficacy through excellent effects of inhibiting production of fatigue substances within a muscle cell, increasing ATP production within the muscle cell, and promoting fat oxidation within the muscle cell, and can be applied to various health functional food compositions and pharmaceutical compositions.

Abstract: An item display system is disclosed that comprises a first component fixable to a support structure, the first component including a plurality of upwardly extending elongate members, and at least one second component engageable with an item to be displayed. Each second component includes a sleeve configured such that the sleeve is engageable with and disengageable from one of the elongate members.

Abstract: Provided herein are a Heartland virus vaccine composition including a messenger ribonucleic acid (mRNA) including an open reading frame (ORF) encoding Gn or Gc of Heartland virus, a Heartland virus vaccine composition comprising a messenger ribonucleic acid (mRNA) comprising an open reading frame (ORF) encoding Gn or Gc of Heartland virus fused with human collagen type I alpha 1 (COL1A1) signal peptide, and a method of inducing immune response against Heartland virus by administering an effective amount of the Heartland virus vaccine composition to a subject in need thereof.

Abstract: The present disclosure relates to a dispensing drum for a sheet material dispenser, the dispensing drum comprising first and second part-cylindrical drum members that are coupled together to form a drum body defining a central axis. The first and second drum members are coupled together by an end piece located adjacent to a first end of the drum body. The end piece comprises a first mounting formation that is engaged with a corresponding first mounting formation provided at the first end of the drum body to form a first coupling, and a second mounting formation that is engaged with a corresponding second mounting formation provided at the first end of the drum body to form a second coupling.

Abstract: Disclosed is an agent capable of inhibiting the activity or enhancing expression of various cancer-related RNAs in TAMS and cancer cells. Disclosed is also a dual-targeted drug delivery system capable of binding to both tumor cells and macrophages in which the PD-L1 receptor is overexpressed.

Abstract: The present invention provides a natural killer T cell ligand-loaded extracellular nanovesicle, and an autologous anticancer vaccine for hematologic malignancies including the above extracellular nanovesicle. More particularly, a cancer cell-derived extracellular nanovesicle in which a natural killer T cell ligand as an adjuvant is bound to a surface thereof, and an autologous anticancer vaccine including the same, which can recognize cancer antigens specific to patients with hematologic malignancies and has cancer cell-specific anticancer function thus to enable T cell activation.

Abstract: An aerosol-generating article according to one aspect of the present disclosure may include a tobacco medium portion and a filter portion coupled to a side of the tobacco medium portion and cooling and filtering an aerosol delivered from the tobacco medium portion. The filter portion may include a first filter segment disposed to be spaced apart from the tobacco medium portion and filtering the aerosol, an inner wrapper surrounding the first filter segment and extending toward the tobacco medium portion, and a second filter segment surrounded by the tobacco medium portion, the first filter segment, and the inner wrapper so as to have a space therein.

Abstract: An aerosol generation product with a low ignition propensity is provided. An aerosol generation product according to some embodiments of the present disclosure is used together with an aerosol generation device, and may include an aerosol formation substrate portion, a filter portion, and a wrapper formed of a flame-retardant paper material and wrapped around at least a portion of the aerosol formation substrate portion. The flame-retardant paper material may improve smoking safety of a user by reducing a possibility of ignition of the wrapper due to an abnormally high temperature during smoking, and may prevent in advance the user from experiencing unintentional smoking, by reducing the possibility of ignition of the aerosol generation product due to an act of ignition by the user.

Abstract: An aerosol generating device includes a first housing, and a second housing positioned in the first housing and configured to accommodate an aerosol generating article, wherein the second housing includes a first layer including a first rim having a first perimeter and a first width and a plurality of first airflow paths formed in the first rim, and a second layer including a second rim connected to the first rim and a second airflow path formed in the second rim, the second airflow path being in fluid connection with the plurality of first airflow paths, the second rim having a second perimeter and a second width.

Abstract: An aerosol-generating article according to one aspect of the present disclosure may include a tobacco medium portion, a filter portion disposed to be spaced apart from the tobacco medium portion, a wrapper surrounding the tobacco medium portion and the filter portion, and a cooling portion surrounded by the tobacco medium portion, the filter portion, and the wrapper so as to have a space therein.

Abstract: An electronic device for heating an aerosol-generating substrate detects insertion of a cigarette, displays an icon corresponding to a type of the cigarette, determines a heating profile based on a user input corresponding to a type of the cigarette, and heats an aerosol-generating substrate of the cigarette based on the heating profile.

Abstract: Proposed is a treatment system using vagus nerve stimulation. The treatment system includes a treatment part including an electrode configured to be worn on at least one of the left and right ears and configured to generate electrical stimulation on the vagus nerve in the auricle, a controller configured to transmit an electrical stimulation signal for generating the electrical stimulation to the treatment part, an input part configured to allow a user to input user information, and a measurement part configured to measure biometric information on the user. The controller adjusts an intensity and a pattern of the electrical stimulation on the basis of the biometric information measured by the measurement part, and adjusts a treatment protocol including treatment time and treatment intensity on the basis of the biometric information measured by the measurement part and the user information input by the input part.

Abstract: Provided is a method of controlling a temperature of a heater included in an aerosol generation device according to a type of cigarette. The method includes receiving temperature profiles of different types of cigarette from a user terminal; sensing a cigarette coupled to the heater after receiving the temperature profiles; identifying a type of the sensed cigarette; selecting a temperature profile corresponding to the identified type from among the temperature profiles; and controlling power supplied from a battery to the heater according to the selected temperature profile.